COGENTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cogentin, and when can generic versions of Cogentin launch?
Cogentin is a drug marketed by Epic Pharma Llc and Merck and is included in two NDAs.
The generic ingredient in COGENTIN is benztropine mesylate. There are seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cogentin
A generic version of COGENTIN was approved as benztropine mesylate by PLIVA on August 10th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COGENTIN?
- What are the global sales for COGENTIN?
- What is Average Wholesale Price for COGENTIN?
Summary for COGENTIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| Clinical Trials: | 5 |
| Patent Applications: | 1,244 |
| Drug Prices: | Drug price information for COGENTIN |
| What excipients (inactive ingredients) are in COGENTIN? | COGENTIN excipients list |
| DailyMed Link: | COGENTIN at DailyMed |
Recent Clinical Trials for COGENTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | Phase 2/Phase 3 |
| University of California, San Diego | Phase 2 |
| National Institute of Mental Health (NIMH) | Phase 4 |
US Patents and Regulatory Information for COGENTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Epic Pharma Llc | COGENTIN | benztropine mesylate | INJECTABLE;INJECTION | 012015-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | COGENTIN | benztropine mesylate | TABLET;ORAL | 009193-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | COGENTIN | benztropine mesylate | TABLET;ORAL | 009193-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | COGENTIN | benztropine mesylate | TABLET;ORAL | 009193-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
